On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Takarazuka City Hospital

InstitutionResearch output, impact & collaborations

Takarazuka City Hospital is a institution indexed in ScholarIQ from OpenAlex.

What is known about Takarazuka City Hospital?

ScholarIQrecord summary

Takarazuka City Hospital is a research organisation in Takarazuka, JP. OpenAlex records 1,620 works and 34,257 citations for it. 372 researchers list it as their most recent affiliation.

How many works does Takarazuka City Hospital have?

ScholarIQindexed works

Takarazuka City Hospital has 1,620 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Takarazuka City Hospital have?

ScholarIQcitation count

Takarazuka City Hospital has 34,257 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Takarazuka City Hospital?

ScholarIQresearcher count

Takarazuka City Hospital has 372 researchers in the ScholarIQ index.

What is the average h-index at Takarazuka City Hospital?

ScholarIQavg h-index

Takarazuka City Hospital has an average h-index of 58 in OpenAlex.

What is the ROR of Takarazuka City Hospital?

ScholarIQror

The ROR for Takarazuka City Hospital is on the source record.

What is the OpenAlex record for Takarazuka City Hospital?

ScholarIQopenalex

The OpenAlex for Takarazuka City Hospital is on the source record.

Who are the most-cited researchers behind Takarazuka City Hospital?

ScholarIQtop researchers by citations
1
Nobuyuki Katakami · Lung Cancer Treatments and Mutations
357 works17,103 citations
2
Takahiro Fukuda · Hematopoietic Stem Cell Transplantation
951 works16,863 citations

What are the most-cited papers on Takarazuka City Hospital?

ScholarIQmost cited works
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia
Yoshiko Atsuta, Ritsuro Suzuki, Tokiko Nagamura‐Inoue, Shuichi Taniguchi, Satoshi Takahashi, Shunro Kai, Hisashi Sakamaki, Yasushi Kouzai, Masaharu Kasai, Takahiro Fukuda, Hiroshi Azuma, Minoko Takanashi, Shinichiro Okamoto, Masahiro Tsuchida, Keisei Kawa, Yasuo Morishima, Yoshihisa Kodera, Shunichi Kato, for the Japan Marrow Donor Program and the Japan Cord Blood Bank Network
Blood. 2008220 CitationsOPEN ACCESS
A Genetic Variant in the IL-17 Promoter Is Functionally Associated with Acute Graft-Versus-Host Disease after Unrelated Bone Marrow Transplantation
J. Luis Espinoza, Akiyoshi Takami, Katsuya Nakata, Makoto Onizuka, Takakazu Kawase, Hideki Akiyama, Koichi Miyamura, Yasuo Morishima, Takahiro Fukuda, Yoshihisa Kodera, Shinji Nakao, for the Japan Marrow Donor Program
PLoS ONE. 2011207 CitationsOPEN ACCESS
Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With <i>EGFR</i> T790M–Mutated Non–Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor
Hiroaki Akamatsu, Yukihiro Toi, Hidetoshi Hayashi, Daichi Fujimoto, Motoko Tachihara, Naoki Furuya, Sakiko Otani, Junichi Shimizu, Nobuyuki Katakami, Koichi Azuma, Naoko Miura, Kazumi Nishino, Satoshi Hara, Shunsuke Teraoka, Satoshi Morita, Kazuhiko Nakagawa, Nobuyuki Yamamoto
JAMA Oncology. 2021187 CitationsOPEN ACCESS
Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L
Yoshiko Urata, Nobuyuki Katakami, Satoshi Morita, Reiko Kaji, Hiroshige Yoshioka, Takashi Seto, Miyako Satouchi, Yasuo Iwamoto, Masashi Kanehara, Daichi Fujimoto, Norihiko Ikeda, Haruyasu Murakami, Haruko Daga, Tetsuya Oguri, Isao Goto, Fumio Imamura, Shunichi Sugawara, Hideo Saka, Naoyuki Nogami, Shunichi Negoro, Kazuhiko Nakagawa, Yoichi Nakanishi
Journal of Clinical Oncology. 2016160 Citations

How much of the research on Takarazuka City Hospital is open access?

ScholarIQopen access share
75%OPEN ACCESS
Gold
25%
Green
0%
Hybrid
25%
Bronze
25%
Closed
25%

Related on ScholarIQ

470M+ articles · 14-day free trial